Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases

The enzymatic activity of CD26/DPP4 (dipeptidyl peptidase 4/DPP4) is highlighted in multiple studies to play a vital role in glucose metabolism by cleaving and inactivating the incretins glucagon-like peptide-1 (GLP) and gastric inhibitory protein (GIP). A large number of studies demonstrate that CD...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaopeng, Wang, Xisheng, Xue, Xingkui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321265/
https://www.ncbi.nlm.nih.gov/pubmed/35889373
http://dx.doi.org/10.3390/molecules27144498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321265/
https://www.ncbi.nlm.nih.gov/pubmed/35889373
http://dx.doi.org/10.3390/molecules27144498

Ejemplares similares